US Stocks
/
ArriVent BioPharma, Inc. Share Price
ArriVent BioPharma, Inc. Share Price

ArriVent BioPharma, Inc. Share Price

NASDAQ: AVBP | Small Cap
$16.73
-$0.11 (-0.65%) Last updated on 09 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

ArriVent BioPharma, Inc. Stock Performance

Open
$16.75
Prev. Close
$16.84
Circuit Range
N/A
Day Range
$15.88 - $16.88
Year Range
$11.37 - $35.59
Volume
1,77,662
Average Traded
$16.28

ArriVent BioPharma, Inc. Share Price Today

As of 9 October 2026, ArriVent BioPharma, Inc.'s share price is $16.73. The stock opened at $16.75, compared to its previous close of $16.84. During today's trading session, ArriVent BioPharma, Inc.'s share price traded between $15.88 and $16.88, with an average price of $16.38. Over the past 52 weeks, the stock has recorded a high of $35.59 and a low of $11.37. In terms of performance, ArriVent BioPharma, Inc.'s share price has declined by 46.21% over the last six months and is down 10.53% on a year-on-year basis.

ArriVent BioPharma, Inc. Share Price Chart

$15.88$16.88
L
Show Current Price
H

ArriVent BioPharma, Inc. Stock Fundamentals & Key Indicators

Market Cap
$643.48M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-3.32
Revenue (TTM)
$0.00
Return On Equity (TTM)
-44.63%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-42.62%

ArriVent BioPharma, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$34.98-$35.54-$43.32-$49.89
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-1.60%-21.89%-15.17%

ArriVent BioPharma, Inc. Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$0.00$0.00
Net Profit-$80.49-$166.31
Net Profit MarginN/AN/A
Income ChangeN/A-106.62%

About ArriVent BioPharma, Inc.

ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. The company focuses on advancing its lead product candidate, firmonertinib, for the treatment of epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer (NSCLC), and developing a pipeline of novel therapeutics, including next-generation antibody-drug conjugates such as ARR-217 (MRG007), with an initial focus on solid tumors.

ArriVent BioPharma, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$30.49
$16.70
-44.98%
Sep 2026
$30.19
$30.36
-2.46%
Aug 2026
$30.58
$31.12
+4.31%
Jul 2026
$34.92
$29.84
-14.09%
Jun 2026
$29.61
$34.73
+14.89%
May 2026
$30.96
$30.23
-2.80%
Apr 2026
$23.41
$31.10
+34.63%
Mar 2026
$22.79
$23.10
+0.20%
Feb 2026
$22.10
$23.05
+2.49%
Jan 2026
$20.47
$22.50
+11.75%
Dec 2025
$22.09
$20.13
-12.25%
Nov 2025
$18.14
$22.94
+22.67%

AVBP Share Price FAQs

What is ArriVent BioPharma, Inc. share price today?

chevron-up
ArriVent BioPharma, Inc. share price today is $16.73 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of ArriVent BioPharma, Inc. stock?

chevron-up
The 52 week high of ArriVent BioPharma, Inc. stock is $35.59, while the 52 week low is $11.37 as of 9 Oct '26.

What is AVBP's market capitalisation today?

chevron-up
AVBP market capitalisation is $643.48M as of October 9, 2026, at 7:15 am IST.

What is AVBP's net income for the last quarter?

chevron-up
AVBP's net income for the last quarter is -49.89B USD.

What is the 5 year returns of AVBP?

chevron-up
The 5 year returns of AVBP is -23.22% as on 9 Oct '26.

What is the high & low stock price of AVBP today?

chevron-up
AVBP stock price hit a high of $16.88 and low of $15.88 as of 9 Oct '26.

Can I buy AVBP shares in India?

chevron-up
Yes. You can buy AVBP in India by opening an international trading account.